Psychedelic Week by Mason Marks
Psychedelic Week is a free newsletter and podcast with detailed analysis of the latest psychedelic policy, news, and events. While many news sources stay above the surface, Psychedelic Week digs into the details. Subscribe for free, and you won’t miss a single installment.
Mason Marks is a Visiting Professor of Law at Harvard Law School, the Florida Bar Health Law Section Professor at Florida State University, the senior fellow and project lead of the Project on Psychedelics Law and Regulation (POPLAR) at the Petrie-Flom Center at Harvard Law School, and a visiting fellow at the Information Society Project at Yale Law School. Marks was previously a fellow-in-residence at the Edmond J. Safra Center for Ethics at Harvard University, and a research scholar at the Information Law Institute at NYU Law School.
Marks’s academic research focuses on drug policy, data protection, and FDA regulation. He is particularly interested in controlled substance regulation and the application of artificial intelligence to medical decision making. Marks’s academic writing has been published or is forthcoming in the Duke Law Journal, Harvard Law Review Forum, Boston University Law Review, Fordham Law Review, Florida Law Review, UC Irvine Law Review, UC Davis Law Review, Administrative Law Review, Yale Journal of Law and Technology, New England Journal of Medicine, JAMA, Nature Medicine, Nature Mental Health, Neuropharmacology, and books by Cambridge University Press.
In addition to legal scholarship, Marks writes about law and technology for publications such as the Washington Post, Los Angeles Times, the Guardian, Seattle Times, Wired, Slate, Vice News, Gizmodo, STAT News, and the Houston Chronicle. His legal commentary has been featured by the New York Times, the Wall Street Journal, the Washington Post, ABC News, Fox News, Bloomberg News, the Economist, the World Health Organization, Radio Boston, NPR's All Things Considered, HBO’s Last Week Tonight with John Oliver, and other platforms.
Marks teaches Constitutional Law, Administrative Law, Drug Law, and Psychedelic Law. An expert on the fast-emerging psychedelics industry, he advises local, state, and federal lawmakers and regulators on the rapidly evolving regulatory landscape regarding controlled substances. He has presented his research at the Food and Drug Administration, the National Institutes of Health, the Department of Health and Human Services, and the National Academies of Sciences, Engineering, and Medicine.
Marks writes about psychedelics and their regulation for his newsletter Psychedelic Week. His book on psychedelic law and politics is under contract with Yale University Press.
*The views expressed on Psychedelic Week do not represent the views of POPLAR at the Petrie-Flom Center at Harvard Law School, Yale Law School, Florida State University College of Law, or any other entity with which the author is associated. Psychedelic Week is an independent project unaffiliated with these programs and institutions.
